Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer

Clinical trial NCT03520686 · TERMINATED

Trial details

NCT number: NCT03520686
Sponsor: ImmunityBio, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2018-05-18
Primary completion: 2025-10-13
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.